🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marwan Fakih

City Of Hope National Medical Center

ORCID: 0000-0002-6554-5488

Also affiliated with City of Hope

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13595

Top 100%

0DataRank

Top 100%0 citations

Riha Vaidya, Cathee Till, Kimlin Ashing, Graham Warren, Dawn L. Hershman +13 more

Papers

Driven by 16 papers — median percentile 0. Top paper: “Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer”.

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.49040

N/A

3.5DataRank · unranked

127 citations

Fang‐Shu Ou, Tyler Zemla, Þorvarður R. Hálfdánarson, Heinz‐Josef Lenz, Rimini Breakstone +11 more

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00382-4

N/A

2.2DataRank · unranked

73 citations

Philippe A. Cassier, Marwan Fakih, Steven Kao, Dorte Nielsen, Antoîne Italiano +17 more

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial

Nature Medicine(2024)10.1038/s41591-023-02717-6

N/A

2.0DataRank · unranked

94 citations

Marwan Fakih, John H. Strickler, Rona Yaeger, Toshiki Masuishi, Edward Kim +14 more

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial

Journal of Clinical Oncology(2025)10.1200/jco-24-01710

N/A

0.458DataRank · unranked

9 citations

Katherine A. Guthrie, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih, Michael J. Overman +15 more

Impact of the Cancer and Aging Research Group (CARG) chemotherapy toxicity (tox) risk score on the benefit of a geriatric assessment–driven intervention (GAIN) among older adults with cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.235

N/A

0DataRank · unranked

0 citations

Can‐Lan Sun, Heeyoung Kim, Enrique Soto‐Pérez‐de‐Celis, Vincent Chung, Marianna Koczywas +13 more

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer

Science Advances(2023)10.1126/sciadv.ade3816

N/A

0DataRank · unranked

68 citations

Arin Nam, Saumya Srivastava, Jeff Jones, Brett Lomenick, Sharad S. Singhal +30 more

The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report

Frontiers in Oncology(2020)10.3389/fonc.2020.00581

N/A

0DataRank · unranked

3 citations

Jingran Ji, James Liu, Manmeet Kaur, Edward Kim, Jun Gong +9 more

Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer: SWOG S2107.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps265

N/A

0DataRank · unranked

8 citations

Katherine A. Guthrie, Scott Kopetz, Rimini Breakstone, Thomas B. Karasic, Zishuo Ian Hu +6 more

A randomized phase 2 study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: SWOG S1613.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.140

N/A

0DataRank · unranked

7 citations

Katherine A. Guthrie, Scott Kopetz, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih +15 more

P-228 Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer: SWOG S2107

Annals of Oncology(2023)10.1016/j.annonc.2023.04.284

N/A

0DataRank · unranked

2 citations

Katherine A. Guthrie, Scott Kopetz, Rimini Breakstone, Thomas B. Karasic, Zelan Hu +7 more

Randomized, phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps784

N/A

0DataRank · unranked

1 citations

Katherine A. Guthrie, Mohamed E. Salem, Katrina S. Pedersen, Aparna Kalyan, Sarah Colby +7 more

The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13595

Top 100%

0DataRank

Top 100%0 citations

Riha Vaidya, Cathee Till, Kimlin Ashing, Graham Warren, Dawn L. Hershman +13 more

Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0212

N/A

0DataRank · unranked

13 citations

Weihua Guo, Chongkai Wang, Colt A. Egelston, Massimo D’Apuzzo, Geereesh Shankar +3 more

Co-stimulatory and co-inhibitory Immune Markers in Solid Tumors With MET Alterations

Future Science OA(2020)10.2144/fsoa-2020-0159

N/A

0DataRank · unranked

2 citations

Jasmine A. McQuerry, Isa Mambetsariev, Rebecca Pharaon, Susan E. Yost, Jeremy Fricke +14 more

Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis

JCI Insight(2021)10.1172/jci.insight.136176

N/A

0DataRank · unranked

21 citations

Yijia Li, Qianqian Zhao, Chunyan Zhang, Nigus D. Ambaye, Jieun Song +7 more

A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses

Advances in Radiation Oncology(2021)10.1016/j.adro.2021.100807

N/A

0DataRank · unranked

9 citations

Ting-Fang He, Massimo D’Apuzzo, Yi‐Jen Chen, Paul Frankel, Michael Tajon +6 more